OPK SEC Filings: 8-K, 10-Q, S-3 & 424B – OPKO Health

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 4, 2026

10-Q/A

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]

Aug 28, 2026

10-Q/A

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]

Aug 28, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Jul 27, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Apr 28, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Feb 26, 2026

News

TYPE

HEADLINE

FILED AT

8-K

OPKO Health Reports Third Quarter 2026 Business Highlights and Financial Results

Nov 4, 2026

8-K

OPKO Health Agrees to Sell BioReference Assets to Laboratory Corporation of America for $722 Million Plus Earn-outs

Oct 15, 2026

8-K

OPKO Health Announces Convertible Senior Notes Due 2029 Are Convertible Through December 31, 2026

Oct 2, 2026

8-K

OPKO Health Issues $125 Million in Additional Senior Secured Notes

Aug 14, 2026

8-K

OPKO Health Reports Second Quarter 2026 Financial Results and Business Highlights

Jul 27, 2026

8-K

OPKO Health, Inc. Announces Results of 2026 Annual Meeting of Stockholders

Jun 18, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

Treasury Stock—549,907 shares at June 30, 2019

Oct 25, 2019

424B5

Treasury Stock—549,907 shares at June 30, 2019

Oct 24, 2019

424B5

Treasury Stock—549,907 shares at June 30, 2019

Oct 22, 2019

424B2

Treasury Stock—549,907 shares at September 30, 2018

Feb 6, 2019

424B7

30,000,000 shares of Common Stock

Feb 5, 2019

424B5

Treasury Stock—549,907 shares at September 30, 2018

Feb 4, 2019

Registrations

TYPE

HEADLINE

FILED AT

S-8

Registration

May 15, 2023

FWP

$200,000,000 Aggregate Principal Amount of

Feb 5, 2019

S-3ASR

Common Stock

Jan 28, 2019

8-A12B

Registration

Jun 23, 2016

S-8

Registration

May 6, 2016

S-8

Registration

Aug 20, 2015

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

May 15, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 30, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 30, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Mar 14, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Mar 14, 2025

DEFR14A

Form DEFR14A - Revised definitive proxy soliciting materials

Aug 30, 2024

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13D/A

OPKO HEALTH, INC. (Filed by)

Nov 6, 2026

PAGANELLI JOHN A (Reporting)

Nov 5, 2026

SCHEDULE 13D

OPKO HEALTH, INC. (Filed by)

Aug 7, 2026

Logal Adam (Reporting)

Jul 28, 2026

Rubin Steven D (Reporting)

Jul 28, 2026

SCHEDULE 13D/A

FROST PHILLIP MD ET AL (Filed by)

Jul 1, 2026

Other

TYPE

HEADLINE

FILED AT

LETTER

Form UPLOAD - SEC-generated letter

Dec 26, 2018

LETTER

Form UPLOAD - SEC-generated letter

Dec 26, 2018

CORRESP

Form CORRESP - Correspondence

Dec 4, 2018

LETTER

Form UPLOAD - SEC-generated letter

Nov 19, 2018

LETTER

Form UPLOAD - SEC-generated letter

Nov 19, 2018

CORRESP

Form CORRESP - Correspondence

Oct 11, 2018

OPKO Health, Inc. OPK · SEC Filings